NPS Pharmaceuticals - Nycomed

NPS Pharmaceuticals is a NASDAQ listed company based in New Jersey, developing specialty therapeutics for gastrointestinal and endocrine disorders.

Nycomed is a privately owned, European specialty pharmaceuticals company with  a strategy of licensing new medicines from research companies and introducing them to Europe

Burrill & Company’s Role

Burrill was retained as an exclusive advisor to NPS to assist in strategic partnering alternatives and creative financing given the large convertible debt overhang

Burrill and NPS successfully closed on:

• A co-development and commercialization partnership for Gattex for all territories outside North America for $185m
• A Drug Royalty Deal for $75m